Appropriateness of implantable cardioverter-defibrillator device implants in the United States
Heart Rhythm · 2024
DOI: 10.1016/j.hrthm.2023.12.005 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Heart Rhythm, 2024. Verfasst von Omair K Yousuf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Carient Heart & Vascular, Manassas, Virginia; Inova Heart and Vascular Institute, Fa…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial, Cardiac Resynchronization Therapy, Heart Failure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute, National Heart, Lung, and Blood Institute, Boston Scientific Corporation.
Abstract (Originalsprache)
BACKGROUND: The appropriate use criteria (AUCs) are a diverse group of indications aimed to better evaluate the benefits of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy. OBJECTIVE: The purpose of this study was to quantify the proportion of ICD and cardiac resynchronization therapy with defibrillator (CRT-D) implants as appropriate, may be appropriate (MA), or rarely appropriate (RA) on the basis of the AUC guidelines. METHODS: This is a multicenter retrospective study of patients within the National Cardiovascular Data Registry undergoing ICD implantation between April 2018 and March 2019 at >1500 US hospitals. The appropriateness of ICD implants was adjudicated using the AUC. RESULTS: Of 309,318 ICDs, 241,438 were primary prevention implants (78.1%) and 67,880 secondary prevention implants (21.9%); 243,532 (79%) were mappable to the AUC. For primary prevention, 185,431 ICDs (96.4%) were appropriate, 5660 (2.9%) MA, and 1205 (0.6%) RA. For secondary prevention, 47,498 ICDs (92.7%) were appropriate, 2581 (5%) MA, and 1157 (2.3%) RA. A significant number of RA devices were implanted in patients with New York Heart Association class IV heart failure who were ineligible for advanced therapies (53.9%) and those with myocardial infarction within 40 days (18.1%). The appropriateness of the pacing lead was more variable, with 48,470 dual-chamber ICD implants (62%) being classified as appropriate, 29,209 (37.4%) MA, and 448 (0.6%) RA. Among CRT-D implants, 63,848 (82.2%) were appropriate, 9900 (12.7%) MA, and 3940 (5.1%) RA for left ventricular pacing. A total of 99,754 implants were deemed appropriate but excluded from Centers for Medicare & Medicaid Services National Coverage Determination. More than 92% of hospitals had an RA implant rate of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Carient Heart & Vascular, Manassas, Virginia; Inova Heart and Vascular Institute, Fairfax, Virginia; University of Virginia Health, Manassas, Virginia. El…
- Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
- Cooper Health, Voorhees, New Jersey.
- University of Colorado, Denver, Colorado.
- Cleveland Clinic, Cleveland, Ohio.
- University of Utah, Salt Lake City, Utah.
Förderung
- Patient-Centered Outcomes Research Institute
- National Heart, Lung, and Blood Institute
- Boston Scientific Corporation
- American Heart Association
- National Institutes of Health
- Sanofi
Zitieren
APA
Yousuf, O. K., Kennedy, K., Russo, A., Varosy, P., Lindsay, B. D., Steinberg, B., Atwater, B. D., Calkins, H., & Spertus, J. A. (2024). Appropriateness of implantable cardioverter-defibrillator device implants in the United States. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2023.12.005
Vancouver
Yousuf OK, Kennedy K, Russo A, Varosy P, Lindsay BD, Steinberg B, et al. Appropriateness of implantable cardioverter-defibrillator device implants in the United States. Heart Rhythm. 2024. doi:10.1016/j.hrthm.2023.12.005
BibTeX
@article{Yousuf2024,
author = {Yousuf, Omair K and Kennedy, Kevin and Russo, Andrea and Varosy, Paul and Lindsay, Bruce D and Steinberg, Benjamin and Atwater, Brett D and Calkins, Hugh and Spertus, John A},
title = {Appropriateness of implantable cardioverter-defibrillator device implants in the United States},
journal = {Heart Rhythm},
year = {2024},
doi = {10.1016/j.hrthm.2023.12.005}
}
EUVIMED